Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT07251998 · RECRUITING
Trial details
- NCT number
- NCT07251998
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-22
- Primary completion
- 2026-10-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.